Growth Metrics

Akari Therapeutics (AKTX) Shareholder's Equity (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Revolution Medicines 32.39 Bn 32.39 Bn - 1.50 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14.38 Mn
Dec 31, 2025 28.33 Mn
Sep 30, 2025 22.69 Mn
Jun 30, 2025 25.61 Mn
Mar 31, 2025 21.75 Mn
Dec 31, 2024 22.23 Mn
Sep 30, 2024 -6.69 Mn
Jun 30, 2024 -3.70 Mn
Mar 31, 2024 -3.55 Mn
Dec 31, 2023 -229,000.00
Sep 30, 2023 213,000.00
Jun 30, 2023 2.78 Mn
Mar 31, 2023 6.56 Mn
Dec 31, 2022 1.79 Mn
Jun 30, 2022 8.33 Mn
Mar 31, 2022 13.93 Mn
Dec 31, 2021 5.56 Mn
Sep 30, 2021 11.36 Mn
Jun 30, 2021 1.59 Mn
Mar 31, 2021 3.94 Mn
Sep 30, 2020 6.95 Mn
Jun 30, 2020 5.96 Mn
Mar 31, 2020 3.27 Mn
Dec 31, 2019 7,598.00
Sep 30, 2019 4.90 Mn
Jun 30, 2019 459,367.00
Mar 31, 2019 4.84 Mn
Dec 31, 2018 4.37 Mn
Sep 30, 2018 128.90 Mn
Jun 30, 2018 22.93 Mn
Mar 31, 2018 -203,447.00
Dec 31, 2017 22.24 Mn
Sep 30, 2017 13.04 Mn
Jun 30, 2017 22.85 Mn
Mar 31, 2017 22.40 Mn
Dec 31, 2016 34.10 Mn
Sep 30, 2016 41.04 Mn
Jun 30, 2016 40.58 Mn
Mar 31, 2016 46.36 Mn
Dec 31, 2015 48.72 Mn
Sep 30, 2015 41.33 Mn
Jun 30, 2015 973,000.00
Mar 31, 2015 2.60 Mn
Dec 31, 2014 2.22 Mn
Jun 30, 2014 10.42 Mn
Dec 31, 2013 400,690.00
Dec 31, 2012 -3.36 Mn
Dec 31, 2011 -2.49 Mn